Skip to content
SSDP/Country guide

🇩🇪 Germany

Cannabis Act 2024 permits adult non-commercial use.

EuropeNo chapter yetDetailed profile

Legal context

European countries vary widely, from decriminalisation and diversion models to criminal penalties, with growing debate on cannabis regulation and health-led responses.

Health response (HRI 2024)

Harm Reduction International (2024) reports at least one operational service in Germany: needle & syringe programmes, opioid agonist therapy, drug consumption rooms, take-home naloxone, peer naloxone distribution, safer smoking kits. Inside prisons: NSP and OAT. National policy documents include an explicit supportive reference to harm reduction.

Youth leadership

Youth participation often happens through civil-society coalitions, student movements, municipal consultations and European-level advocacy networks.

Cannabis Act 2024 permits adult non-commercial use.

Drug policy briefing

What young people should know about drug policy in Germany

Decriminalisation

Cannabis legal for adults

The 2024 Cannabis Act (CanG) legalised personal cannabis use, home cultivation and cannabis social clubs. Other substances remain criminalised.

Evidence · Cannabis Act (CanG) 2024.

Harm Reduction

Established, expanding

OAT, needle exchange and drug consumption rooms operate in most large cities; drug-checking is expanding.

Evidence · BZgA; EMCDDA.

Youth Participation

Advisory role

Youth and civil society organisations participate in federal and Länder drug policy consultations.

Evidence · BZgA.

Treatment Systems

Statutory insurance

Treatment is covered by statutory health insurance with broad OAT availability.

Evidence · BZgA; EMCDDA.

Sources · Harm Reduction International, Global State of Harm Reduction 2024 · UNODC · WHO · EMCDDA/EUDA · national laws and civil-society monitoring. Last reviewed Harm Reduction International 2024.